Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands

This publication has 14 references indexed in Scilit:

• 1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: Application in the synthesis of potent human melanocortin-4 receptor selective agonists
  Bioorganic & Medicinal Chemistry Letters, 2005
• Ligands of the melanocortin receptors, 2002 – 2003 update
  Expert Opinion on Therapeutic Patents, 2004
• Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
  Pharmacological Reviews, 2004
• The MC4 receptor as a therapeutic target
  Drugs of the Future, 2004
• Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist
  Journal of Medicinal Chemistry, 2002
• Selective, High Affinity Peptide Antagonists of α-Melanotropin Action at Human Melanocortin Receptor 4: Their Synthesis and Biological Evaluation in Vitro
  Journal of Medicinal Chemistry, 2001
• Melanocortin receptors: new opportunities in drug discovery
  Expert Opinion on Therapeutic Patents, 2001
• Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
  Nature, 1997
• Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor
  Nature, 1994
• Molecular characterization of the mouse agouti locus
  Cell, 1992